These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 19538971)
1. Oritavancin binds to isolated protoplast membranes but not intact protoplasts of Staphylococcus aureus. Kim SJ; Singh M; Schaefer J J Mol Biol; 2009 Aug; 391(2):414-25. PubMed ID: 19538971 [TBL] [Abstract][Full Text] [Related]
2. Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance. Kim SJ; Cegelski L; Preobrazhenskaya M; Schaefer J Biochemistry; 2006 Apr; 45(16):5235-50. PubMed ID: 16618112 [TBL] [Abstract][Full Text] [Related]
3. Desleucyl-Oritavancin with a Damaged d-Ala-d-Ala Binding Site Inhibits the Transpeptidation Step of Cell-Wall Biosynthesis in Whole Cells of Staphylococcus aureus. Kim SJ; Singh M; Sharif S; Schaefer J Biochemistry; 2017 Mar; 56(10):1529-1535. PubMed ID: 28221772 [TBL] [Abstract][Full Text] [Related]
4. Locations of the hydrophobic side chains of lipoglycopeptides bound to the peptidoglycan of Staphylococcus aureus. Kim SJ; Tanaka KS; Dietrich E; Rafai Far A; Schaefer J Biochemistry; 2013 May; 52(20):3405-14. PubMed ID: 23607653 [TBL] [Abstract][Full Text] [Related]
5. Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus. Kim SJ; Cegelski L; Stueber D; Singh M; Dietrich E; Tanaka KS; Parr TR; Far AR; Schaefer J J Mol Biol; 2008 Mar; 377(1):281-93. PubMed ID: 18258256 [TBL] [Abstract][Full Text] [Related]
6. Conformational and quantitative characterization of oritavancin-peptidoglycan complexes in whole cells of Staphylococcus aureus by in vivo 13C and 15N labeling. Cegelski L; Steuber D; Mehta AK; Kulp DW; Axelsen PH; Schaefer J J Mol Biol; 2006 Apr; 357(4):1253-62. PubMed ID: 16483598 [TBL] [Abstract][Full Text] [Related]
7. Bacterial cell wall composition and the influence of antibiotics by cell-wall and whole-cell NMR. Romaniuk JA; Cegelski L Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1679):. PubMed ID: 26370936 [TBL] [Abstract][Full Text] [Related]
8. Vancomycin and oritavancin have different modes of action in Enterococcus faecium. Patti GJ; Kim SJ; Yu TY; Dietrich E; Tanaka KS; Parr TR; Far AR; Schaefer J J Mol Biol; 2009 Oct; 392(5):1178-91. PubMed ID: 19576226 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Staphylococcus aureus Cell Wall Biosynthesis by Desleucyl-Oritavancin: a Quantitative Peptidoglycan Composition Analysis by Mass Spectrometry. Chang JD; Foster EE; Thadani AN; Ramirez AJ; Kim SJ J Bacteriol; 2017 Aug; 199(15):. PubMed ID: 28507244 [TBL] [Abstract][Full Text] [Related]
11. Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin. Münch D; Engels I; Müller A; Reder-Christ K; Falkenstein-Paul H; Bierbaum G; Grein F; Bendas G; Sahl HG; Schneider T Antimicrob Agents Chemother; 2015 Feb; 59(2):772-81. PubMed ID: 25403671 [TBL] [Abstract][Full Text] [Related]
12. Oritavancin: mechanism of action. Zhanel GG; Schweizer F; Karlowsky JA Clin Infect Dis; 2012 Apr; 54 Suppl 3():S214-9. PubMed ID: 22431851 [TBL] [Abstract][Full Text] [Related]